Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting

NeuroImage: Clinical

Volumn 6, Issue , 2014, Pages 445-454

  Perani, Daniela ^a,b,c   Della Rosa, Pasquale Anthony ^c   Cerami, Chiara ^a   Gallivanone, Francesca ^c   Fallanca, Federico ^a   Vanoli, Emilia Giovanna ^a   Panzacchi, Andrea ^a   Nobili, Flavio ^d   Pappatà, Sabina ^e   Marcone, Alessandra ^d   Garibotto, Valentina ^f   Castiglioni, Isabella ^c   Magnani, Giuseppe ^a   Cappa, Stefano F ^a   Gianolli, Luigi ^a   Drzezga, Alexander ^g   Perneczky, Robert ^g   Didic, Mira ^g   Guedj, Eric ^g   Van Berckel, Bart N ^g   Ossenkoppele, Rik ^g   Morbelli, Silvia ^g   Frisoni, Giovanni ^g   Caroli, Anna ^g   more..

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c INSTITUTE OF MOLECULAR BIOIMAGING AND PHYSIOLOGY   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e CNR   (Italy)

^f UNIVERSITY OF GENEVA   (Switzerland)

^g NONE   (Italy)

Author keywords

Dementia diagnosis; FDG PET imaging; Statistical parametrical mapping; Voxel based analysis

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ALZHEIMER DISEASE; ANTERIOR CINGULATE; ARTICLE; BRAIN MAPPING; BRAIN METABOLISM; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; DEMENTIA; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; FEMALE; FOLLOW UP; FRONTAL CORTEX; FRONTAL VARIANT FRONTOTEMPORAL DEMENTIA; FRONTOTEMPORAL DEMENTIA; HUMAN; INTERRATER RELIABILITY; MAJOR CLINICAL STUDY; MALE; MEDIAL FRONTAL CORTEX; MEDICAL EXPERT; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; POSTERIOR CINGULATE; PREDICTIVE VALUE; PRIMARY PROGRESSIVE APHASIA; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; STATISTICAL PARAMETRICAL MAPPING; SUPERIOR ANTERIOR TEMPORAL CORTEX; TEMPORAL CORTEX; VALIDATION STUDY; VOXEL BASED MORPHOMETRY; BRAIN; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC USE; METABOLISM; MIDDLE AGED; NEURODEGENERATIVE DISEASES; PROCEDURES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BRAIN; DATA INTERPRETATION, STATISTICAL; DIAGNOSIS, COMPUTER-ASSISTED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; POSITRON-EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY;

EID: 84910087093     PISSN: None     EISSN: 22131582     Source Type: Journal    
DOI: 10.1016/j.nicl.2014.10.009     Document Type: Article

References (49)

1. Albert, M.S., DeKosky, S.T., Dickson, D., et al., 2011. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia: the Journal of the Alzheimer's Association 7 (3), 270-279. http://dx.doi.org/10.1016/j.jalz.2011.03.00821514249.
2. Anchisi, D., Borroni, B., Franceschi, M., et al., 2005. Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease. Archives of Neurology 62 (11), 1728-1733. http://dx.doi.org/10.1001/archneur.62.11.172816286547.
3. Armstrong, M.J., Litvan, I., Lang, A.E., et al., 2013. Criteria for the diagnosis of corticobasal degeneration. Neurology 80 (5), 496-503. http://dx.doi.org/10.1212/WNL.0b013e31827f0fd123359374.
4. Bateman, R.J., Xiong, C., Benzinger, T.L., et al., 2012. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. New England Journal of Medicine 367 (9), 795-804. http://dx.doi.org/10.1056/NEJMoa120275322784036.
5. 18F-FDG PET in the evaluation of dementia: a review of the recent literature. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine 53 (1), 59-71. http://dx.doi.org/10.2967/jnumed.111.09657822173840.
6. Buchert, R.,Wilke, F., Chakrabarti, B.,Martin, B., Brenner, W., Mester, J., Clausen, M., 2005. Adjusted scaling of FDG positron emission tomography images for statistical evaluation in patientswith suspected Alzheimer's disease. Journal of Neuroimaging: Official Journal of the American Society of Neuroimaging 15 (4), 348-355. http://dx.doi.org/10.1177/105122840528016916254400.
7. 18F-FDG PET: head-to-head comparison. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine 53 (4), 592-600. http://dx.doi.org/10.2967/jnumed.111.09494622343502.
8. Chen, W.P., Samuraki, M., Yanase, D., et al., 2008. Effect of sample size for normal database on diagnostic performance of brain FDG PET for the detection of Alzheimer's disease using automated image analysis. Nuclear Medicine Communications 29 (3), 270-276. http://dx.doi.org/10.1097/MNM.0b013e3282f3fa7618349798.
9. Chételat, G., Desgranges, B., Landeau, B., et al., 2008. Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease. Brain: A Journal of Neurology 131 (1), 60-71. http://dx.doi.org/10.1093/brain/awm28818063588.
10. De Souza, L.C., Chupin, M., Bertoux,M., et al., 2013. Is hippocampal volume a good marker to differentiate Alzheimer's disease from frontotemporal dementia? Journal of Alzheimer's Disease: JAD 36 (1), 57-66. http://dx.doi.org/10.3233/JAD-12229323542864.
11. 18F]FDG-PET template for spatial normalization in statistical parametric mapping analysis pf brain images in dementia. Neuroinformatics http://dx.doi.org/10.1007/s12021-014-9235-424952892.
12. Dubois, B., Epelbaum, S., Santos, A., et al., 2013. Alzheimer disease: from biomarkers to diagnosis. Revue Neurologique 169 (10), 744-751. http://dx.doi.org/10.1016/j.neurol.2013.07.016.
13. Dubois, B., Feldman, H.H., Jacova, C., et al., 2014. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. Lancet. Neurology 13 (6), 614-629. http://dx.doi.org/10.1016/S1474-4422(14)70090-024849862.
14. Dubois, B., Feldman, H.H., Jacova, C., et al., 2010. Revising the definition of Alzheimer's disease: a new lexicon. Lancet. Neurology 9 (11), 1118-1127. http://dx.doi.org/10.1016/S1474-4422(10)70223-420934914.
15. Fjell, A.M., McEvoy, L., Holland, D., Dale, A.M., Walhovd, K.B., Alzheimer's Disease Neuroimaging Initiative, 2013. Brain changes in older adults at very low risk for Alzheimer's disease. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 33 (19), 8237-8242. http://dx.doi.org/10.1523/JNEUROSCI.5506-12.201323658162.
16. Foster, N.L., Heidebrink, J.L., Clark, C.M., et al., 2007. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain: A Journal of Neurology 130 (10), 2616-2635. http://dx.doi.org/10.1093/brain/awm17717704526.
17. Fotuhi, M., Do, D., Jack, C., 2012. Modifiable factors that alter the size of the hippocampus with ageing. Nature Reviews. Neurology 8 (4), 189-202. http://dx.doi.org/10.1038/nrneurol.2012.2722410582.
18. Frisoni, G.B., Bocchetta, M., Chételat, G., et al., 2013. Imaging markers for Alzheimer disease: which vs how. Neurology 81 (5), 487-500. http://dx.doi.org/10.1212/WNL.0b013e31829d86e823897875.
19. Friston, K.J., Holmes, A.P.,Worsley, K.J., Poline, J.-P., Frith, C.D., Frackowiak, R.S.J., 1994. Statistical parametric maps in functional imaging: a general linear approach. Human Brain Mapping 2 (4), 189-210. http://dx.doi.org/10.1002/hbm.460020402.
20. Galluzzi, S., Geroldi, C., Amicucci, G., et al., 2013. Supporting evidence for using biomarkers in the diagnosis of MCI due to AD. Journal of Neurology 260 (2), 640-650. http://dx.doi.org/10.1007/s00415-012-6694-023070466.
21. Gorno-Tempini, M.L., Hillis, A.E., Weintraub, S., et al., 2011. Classification of primary progressive aphasia and its variants. Neurology 76 (11), 1006-1114. http://dx.doi.org/10.1212/WNL.0b013e31821103e621325651.
22. Herholz, K., 2010. Cerebral glucosemetabolismin preclinical and prodromal Alzheimer's disease. Expert Review of Neurotherapeutics 10 (11), 1667-1673. http://dx.doi.org/10.1586/ern.10.13620977325.
23. Herholz, K., Salmon, E., Perani, D., et al., 2002. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage 17 (1), 302-306. http://dx.doi.org/10.1006/nimg.2002.120812482085.
24. Jack Jr, C.R., Albert, M.S., Knopman, D.S., et al., 2011. Introduction to the recommendations from the National Institute on Aging-Alzheimer's Associationworkgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia: the Journal of the Alzheimer's Association 7 (3), 257-262. http://dx.doi.org/10.1016/j.jalz.2011.03.00421514247.
25. Jack Jr, C.R., Knopman, D.S., Jagust, W.J., et al., 2010. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet. Neurology 9 (1), 119-128. http://dx.doi.org/10.1016/S1474-4422(09)70299-620083042.
26. McKeith, I.G., Dickson, D.W., Lowe, J., et al., 2005. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65 (12), 1863-1872. http://dx.doi.org/10.1212/01.wnl.0000187889.17253.b116237129.
27. McKhann, G.M., Knopman, D.S., Chertkow, H., et al., 2011. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging- Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia: the Journal of the Alzheimer's Association 7 (3), 263-269. http://dx.doi.org/10.1016/j.jalz.2011.03.00521514250.
28. Minoshima, S., Foster, N.L., Sima, A.A., Frey, K.A., Albin, R.L., Kuhl, D.E., 2001. Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Annals of Neurology 50 (3), 358-365. http://dx.doi.org/10.1002/ana.113311558792.
29. Minoshima, S., Giordani, B., Berent, S., Frey, K.A., Foster, N.L., Kuhl, D.E., 1997. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Annals of Neurology 42 (1), 85-94. http://dx.doi.org/10.1002/ana.4104201149225689.
30. Morbelli, S., Drzezga, A., Perneczky, R., et al., 2012. Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project. Neurobiology of Aging 33 (11), 2533-2550. http://dx.doi.org/10.1016/j.neurobiolaging.2012.01.00522365486.
31. Mosconi, L., Murray, J., Tsui, W.H., et al., 2014. Brain imaging of cognitively normal individuals with 2 parents affected by late-onset AD. Neurology 82 (9), 752-760. http://dx.doi.org/10.1212/WNL.000000000000018124523481.
32. 18F-FDG PET diagnosis ofmild cognitive impairment, Alzheimer's disease, and other dementias. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine 49 (3), 390-398. http://dx.doi.org/10.2967/jnumed.107.04538518287270.
33. Patterson, J.C., Lilien, D.L., Takalkar, A., Pinkston, J.B., 2010. Early detection of brain pathology suggestive of early AD using objective evaluation of FDG-PET scans. International Journal of Alzheimer's Disease 2011. http://dx.doi.org/10.4061/2011/94659020885966.
34. Perani, D., 2014. FDG-PET and amyloid-PET imaging: the diverging paths. Current Opinion in Neurology 27 (4), 405-413. http://dx.doi.org/10.1097/WCO.000000000000010924927239.
35. Perani, D., 2008. Functional Neuroimaging of Cognition. Handbook of Clinical Neurology 88, pp. 61-111.
36. Perani, D., Schillaci, O., Padovani, A., et al., 2014. A survey of FDG and amyloid PET imaging in dementia and GRADE analysis. BioMed Research International 2014, 785039.
37. Petersen, R.C., Roberts, R.O., Knopman, D.S., et al., 2009.Mild cognitive impairment: ten years later. Archives of Neurology 66 (12), 1447-1455. http://dx.doi.org/10.1001/archneurol.2009.26620008648.
38. Prestia, A., Caroli, A., van der Flier,W.M., et al., 2013. Prediction of dementia in MCI patients based on core diagnosticmarkers for Alzheimer disease. Neurology 80 (11), 1048-1056. http://dx.doi.org/10.1212/WNL.0b013e318287283023390179.
39. Rascovsky, K., Hodges, J.R., Knopman, D., et al., 2011. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134 (9), 2456-2477.
40. Ridgway, G.R., Omar, R., Ourselin, S., Hill, D.L., Warren, J.D., Fox, N.C., 2009. Issues with threshold masking in voxel-based morphometry of atrophied brains. Neuroimage 44 (1), 99-111. http://dx.doi.org/10.1016/j.neuroimage.2008.08.04518848632.
41. Salmon, E., Garraux, G., Delbeuck, X., et al., 2003. Predominant ventromedial frontopolar metabolic impairment in frontotemporal dementia. Neuroimage 20 (1), 435-440. http://dx.doi.org/10.1016/S1053-8119(03)00346-X14527604.
42. 18F]FDG PET: a clinical validation of statistical parametric mapping. Neuroimage 9 (1), 63-80. http://dx.doi.org/10.1006/nimg.1998.03819918728.
43. Silverman, D.H., Mosconi, L., Ercoli, L., Chen, W., Small, G.W., 2008. Positron emission tomography scans obtained for the evaluation of cognitive dysfunction. Seminars in Nuclear Medicine 38 (4), 251-261. http://dx.doi.org/10.1053/j.semnuclmed.2008.02.00618514081.
44. Silverman, D.H., Truong, C.T., Kim, S.K., et al., 2003. Prognostic value of regional cerebral metabolism in patients undergoing dementia evaluation: comparison to a quantifying parameter of subsequent cognitive performance and to prognostic assessment without PET. Molecular Genetics and Metabolism 80 (3), 350-355. http://dx.doi.org/10.1016/S1096-7192(03)00139-214680983.
45. Spence, J.S., Carmack, P.S., Gunst, R.F., Schucany, W.R., Woodward, W.A., Haley, R.W., 2006. Using a white matter reference to remove the dependency of global signal on experimental conditions in SPECT analyses. Neuroimage 32 (1), 49-53. http://dx.doi.org/10.1016/j.neuroimage.2006.03.02516651010.
46. Sperling, R.A., Aisen, P.S., Beckett, L.A., et al., 2011. Toward defining the preclinical stage of Alzheimer's disease: recommendations from the National Institute on Aging- Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia: the Journal of the Alzheimer's Association 7 (3), 280-292. http://dx.doi.org/10.1016/j.jalz.2011.03.00321514248.
47. Teune, L.K., Bartels, A.L., de Jong, B.M., et al., 2010. Typical cerebralmetabolic patterns in neurodegenerative brain diseases. Movement Disorders: Official Journal of the Movement Disorder Society 25 (14), 2395-2404. http://dx.doi.org/10.1002/mds.2329120669302.
48. 18 F]FDG, version 2. European Journal of Nuclear Medicine and Molecular Imaging 36 (12), 2103-2110. http://dx.doi.org/10.1007/s00259-009-1264-019838705.
49. Yakushev, I., Hammers, A., Fellgiebel, A., et al., 2009. SPM-based count normalization provides excellent discrimination of mild Alzheimer's disease and amnestic mild cognitive impairment from healthy aging. Neuroimage 44 (1), 43-50. http://dx.doi.org/10.1016/j.neuroimage.2008.07.01518691659.